You’re missing the big win here: National coverage for CYDY. This is important so the phase 2 trials for COVID19 will fill quickly as more doctors and hospitals are aware of the drug.

Yes, there have been small errors in the various articles published in the last 24 hours regarding the emergency IND patients. That’s going to happen with only a few patients injected and official information hard to come by, but it’s a start.